Mechanism of action of amylin in bone
暂无分享,去创建一个
I. Owan | C. Miyaura | T. Tamura | T. Suda | Ichiro Owan
[1] H. Lodish,et al. Expression cloning of an adenylate cyclase-coupled calcitonin receptor. , 1991, Science.
[2] T. Martin,et al. Structure‐activity relationships in calcitonin gene‐related peptide: Cyclic AMP response in a preosteoblast cell line (ks‐4) , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] M. Zaidi,et al. Selective antagonism of calcitonin-induced osteoclastic quiescence (Q effect) by human calcitonin gene-related peptide-(Val8Phe37). , 1991, Biochemical and biophysical research communications.
[4] S. Gardiner,et al. Antagonistic Effect of Human α-Calcitonin Gene–Related Peptide (8–37) on Regional Hemodynamic Actions of Rat Islet Amyloid Polypeptide in Conscious Long-Evans Rats , 1991, Diabetes.
[5] A. Saltiel,et al. Amylin increases cyclic AMP formation in L6 myocytes through calcitonin gene-related peptide receptors. , 1991, Biochemical and biophysical research communications.
[6] R. Fisher,et al. Characterization and regulation of high affinity calcitonin gene-related peptide receptors in cultured neonatal rat cardiac myocytes. , 1991, Endocrinology.
[7] N. Udagawa,et al. Role of prostaglandins in interleukin‐1‐induced bone resorption in mice in vitro , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[8] N. Udagawa,et al. Cloning of an osteoblastic cell line involved in the formation of osteoclast‐like cells , 1990, Journal of cellular physiology.
[9] S. Gardiner,et al. Antagonistic effect of human α-CGRP [8–37] on the in vivo regional haemodynamic actions of human α-CGRP , 1990 .
[10] H. Datta,et al. Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathways. , 1990, The Journal of endocrinology.
[11] H. Datta,et al. Amylin‐amide: a new bone‐conserving peptide from the pancreas , 1990, Experimental physiology.
[12] R. Epand,et al. Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs. , 1990, Endocrinology.
[13] D. Steiner,et al. Islet amyloid polypeptide. A new beta cell secretory product related to islet amyloid deposits. , 1990, The Journal of biological chemistry.
[14] T. Martin,et al. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. , 1989, Endocrinology.
[15] H. Datta,et al. In vivo and in vitro effects of amylin and amylin-amide on calcium metabolism in the rat and rabbit. , 1989, Biochemical and biophysical research communications.
[16] S. Bloom,et al. Expression of the rat amylin (IAPP/DAP) gene. , 1989, Journal of molecular endocrinology.
[17] C. Newgard,et al. Rat amylin: cloning and tissue-specific expression in pancreatic islets. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[18] H. Makino,et al. Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. , 1989, Biochemical and biophysical research communications.
[19] T. Martin,et al. Effects of calcitonin gene‐related peptide on cyclic AMP formation in chicken, rat, and mouse bone cells , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[20] G. Cooper,et al. Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro , 1988, Nature.
[21] J. Rothbard,et al. Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Schultzberg,et al. Substance P- and CGRP-immunoreactive nerves in bone , 1988, Peptides.
[23] R. Turner,et al. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[24] C. Wernstedt,et al. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. , 1986, Biochemical and biophysical research communications.
[25] P. Sexton,et al. Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and autoradiographic characterization. , 1986, The Journal of clinical investigation.
[26] K. Kasono,et al. Stimulation of prostaglandin E2 and bone resorption by recombinant human interleukin 1 alpha in fetal mouse bones. , 1986, Biochemical and biophysical research communications.
[27] G. Mundy,et al. Human synthetic calcitonin gene-related peptide inhibits bone resorption in vitro. , 1986, Endocrinology.
[28] H. Morris,et al. The myotropic and plasma-calcium modulating effects of calcitonin gene-related peptide (CGRP) , 1984, Neuropeptides.
[29] H. Nakamuta,et al. Binding sites of calcitonin gene-related peptide (CGRP): abundant occurrence in visceral organs. , 1986, Japanese journal of pharmacology.
[30] L. Raisz. BONE RESORPTION IN TISSUE CULTURE. FACTORS INFLUENCING THE RESPONSE TO PARATHYROID HORMONE. , 1965, The Journal of clinical investigation.